BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27683445)

  • 1. Clinical Application of Pharmacogenetics: Where are We Now?
    van Schaik RH;
    EJIFCC; 2013 Feb; 24(3):105-12. PubMed ID: 27683445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines.
    Abdullah-Koolmees H; van Keulen AM; Nijenhuis M; Deneer VHM
    Front Pharmacol; 2020; 11():595219. PubMed ID: 33568995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
    van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
    Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients.
    Dong OM; Li A; Suzuki O; Oni-Orisan A; Gonzalez R; Stouffer GA; Lee CR; Wiltshire T
    Pharmacogenomics; 2018 Jun; 19(9):771-782. PubMed ID: 29793377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics data.
    Kordou Z; Skokou M; Tsermpini EE; Chantratita W; Fukunaga K; Mushiroda T; Patrinos GP; Koromina M
    Pharmacol Res; 2021 May; 167():105538. PubMed ID: 33705851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics research and clinical implementation in Brazil.
    Rodrigues-Soares F; Suarez-Kurtz G
    Basic Clin Pharmacol Toxicol; 2019 May; 124(5):538-549. PubMed ID: 30589990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard.
    Alshabeeb MA; Alyabsi M; Paras B
    Saudi Pharm J; 2022 Aug; 30(8):1181-1192. PubMed ID: 36164570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal pharmacogenomics: A promising addition to complex neonatal care.
    Raymond M; Critchlow E; Rice SM; Wodoslawsky S; Berger SI; Hegde M; Empey PE; Al-Kouatly HB
    Mol Genet Metab; 2022; 137(1-2):140-145. PubMed ID: 36029725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
    Pritchard D; Patel JN; Stephens LE; McLeod HL
    Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for pharmacogenetic testing in clinical practice guidelines in the US.
    Hertz DL; Bousman CA; McLeod HL; Monte AA; Voora D; Orlando LA; Crutchley RD; Brown B; Teeple W; Rogers S; Patel JN
    Am J Health Syst Pharm; 2024 Apr; ():. PubMed ID: 38652504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System.
    Selig DJ; Livezey JR; Chin GC; DeLuca JP; Guillory Ii WO; Kress AT; Oliver TO; Por ED
    Mil Med; 2021 Dec; 187(Suppl 1):9-17. PubMed ID: 34967405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.
    Caudle KE; Sangkuhl K; Whirl-Carrillo M; Swen JJ; Haidar CE; Klein TE; Gammal RS; Relling MV; Scott SA; Hertz DL; Guchelaar HJ; Gaedigk A
    Clin Transl Sci; 2020 Jan; 13(1):116-124. PubMed ID: 31647186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
    Matey ET; Ragan AK; Oyen LJ; Vitek CR; Aoudia SL; Ragab AK; Fee-Schroeder KC; Black JL; Moyer AM; Nicholson WT; Shrestha S; McAllister TM; Sinnwell JP; Faubion SS; Lazaridis KN
    Pharmacogenomics J; 2022 Feb; 22(1):69-74. PubMed ID: 34671112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADME Gene-Related Pharmacogenomic Labeling of FDA-Approved Drugs: Comparison with Clinical Pharmacogenetics Implementation Consortium (CPIC) Evidence Levels.
    Deb S; Hopefl R; Reeves AA; Cvetkovic D
    Medicines (Basel); 2024 Feb; 11(3):. PubMed ID: 38535119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer.
    Bernard PS; Wooderchak-Donahue W; Wei M; Bray SM; Wood KC; Parikh B; McMillin GA
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33799547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost Effectiveness of Pharmacogenetic Testing for Drugs with Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines: A Systematic Review.
    Morris SA; Alsaidi AT; Verbyla A; Cruz A; Macfarlane C; Bauer J; Patel JN
    Clin Pharmacol Ther; 2022 Dec; 112(6):1318-1328. PubMed ID: 36149409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients.
    Niedrig DF; Rahmany A; Heib K; Hatz KD; Ludin K; Burden AM; Béchir M; Serra A; Russmann S
    J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34361984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics Biomarkers Predictive of Drug Pharmacodynamics as an Additional Tool to Therapeutic Drug Monitoring.
    Haufroid V; Picard N
    Ther Drug Monit; 2019 Apr; 41(2):121-130. PubMed ID: 30883506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Pharmacogenetic Drugs by the Dutch Population.
    Alshabeeb MA; Deneer VHM; Khan A; Asselbergs FW
    Front Genet; 2019; 10():567. PubMed ID: 31312209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.